Two clinical trials in which researchers formulated personalized vaccines tailored to treat several patients with melanoma have shown promise in staving off tumors. After receiving the vaccines, most of the patients experienced a complete remission or saw their tumors shrink in size, proving hopeful for the future of cancer immunotherapy. Read more here.
Last Updated on May 13, 2020 by Aimed Alliance
